Austar Lifesciences Ltd. | Income Statement
Fiscal year is January-December. All values HKD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
889,704.30
855,485.40
774,063.40
785,814.00
630,661.30
967,207.30
Cost of Goods Sold (COGS) incl. D&A
621,343.20
567,776.80
583,802.70
599,209.40
491,427.20
726,892.20
Gross Income
268,361.10
287,708.70
190,260.70
186,604.60
139,234.10
240,315
SG&A Expense
177,917.40
183,752.90
190,107.70
199,314.70
226,838.70
250,973.90
EBIT
89,728.40
106,539.60
3,680.70
27,018.50
87,575.80
10,658.90
Unusual Expense
-
-
1,650.40
-
-
4,816
Non Operating Income/Expense
1,690.70
485.80
4,192.60
2,875.50
2,554.10
1,507.80
Interest Expense
1,700.80
2,359.70
2,494.10
1,230.30
1,410.20
1,711.50
Pretax Income
91,303.00
105,214.30
2,878.90
24,415.30
73,337.50
9,669.90
Income Tax
24,438.20
28,483.00
1,488.80
1,365.90
4,869.50
4,001.10
Equity in Affiliates
5,671.40
5,316.00
6,483.20
3,966.80
5,974.10
13,813.10
Consolidated Net Income
72,536.20
82,047.30
7,873.30
21,814.40
62,493.90
142.10
Net Income
72,536.20
82,047.30
7,874.50
21,814.40
62,364.70
126.70
Net Income After Extraordinaries
72,536.20
82,047.30
7,874.50
21,814.40
62,364.70
126.70
Net Income Available to Common
72,536.20
82,047.30
7,874.50
21,814.40
62,364.70
126.70
EPS (Basic)
0.14
0.21
0.01
0.05
0.13
-
Basic Shares Outstanding
512,582.00
394,424.00
512,582.00
512,582.00
512,582.00
512,582
EPS (Diluted)
0.14
0.21
0.02
0.04
0.12
-
Diluted Shares Outstanding
512,582.00
394,424.00
512,582.00
512,582.00
512,582.00
512,582
EBITDA
97,432.40
116,469.40
16,563.20
13,617.90
77,533.60
142.10
Other Operating Expense
715.40
2,583.80
3,527.80
14,308.50
28.80
-
Non-Operating Interest Income
1,584.70
1,520.30
4,234.50
4,735.60
4,995.20
6,008.70
Minority Interest Expense
-
-
1.20
-
129.10
15.40
About Austar Lifesciences
View Profile
